Physician profile
Samuel Simone
NPI 1245499920
$17,680.87
in general payments reported to CMS, 2019-2025
26 companies · $16K in 2025
The $16K reported for 2025 was more than what 93% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $189 · 2020: $106 · 2021: $212 · 2022: $224 · 2023: $470 · 2024: $208 · 2025: $16K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $16K · Food and Beverage: $1,151 · Travel and Lodging: $199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $15,600.00 |
| Food and Beverage | $1,150.99 |
| Travel and Lodging | $199.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $15,641.94 | 2025 | |
| W. L. Gore & Associates, INC. | $454.25 | 2019-2023 | Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Tag Thoracic Branch Endoprosthesis, Gore Excluder Iliac Branch Endoprosthesis |
| Smith+Nephew, INC. | $264.13 | 2020-2025 | Grafix Pl, Collagenase Santyl, Renasys Go V2 Home |
| Bard Peripheral Vascular, INC. | $212.20 | 2021-2024 | Venovo, Venclose Maven Catheter |
| Philips North America LLC | $207.50 | 2025 | Igt Devices Undivided |
| Silk Road Medical, INC. | $103.28 | 2021-2022 | |
| Stryker Corporation | $92.56 | 2025 | Flowtriever, Artix Mt |
| Tactile Systems Technology INC | $91.41 | 2021-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Misonix INC | $82.83 | 2019-2021 | |
| Lemaitre Vascular, INC. | $70.02 | 2022-2025 | Syntel Embolectomy Catheter (Spring Tip), Artegraft Vascular Graft, Xenosure Biologic Patch |
| Lifenet Health | $60.76 | 2024 | Theragenesis Wound Matrix |
| Davol INC. | $57.26 | 2020-2022 | |
| Abbott Laboratories | $46.41 | 2023 | Jeti, Jeti Peripheral Catheter |
| Boston Scientific Corporation | $38.69 | 2023 | Embold Fibered |
| Neuros Medical, INC. | $36.87 | 2025 | Altius |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Terumo Medical Corporation | $26.60 | 2025 | Navicross |
| Biowound Solutions, INC. | $24.98 | 2025 | Bio-Connekt |
| Cardiva Medical, INC. | $23.32 | 2023 | Cardiva Vascade 6/7f Vcs |
| Integra Lifesciences Corporation | $23.18 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Acera Surgical, INC. | $22.26 | 2025 | Restrata Wound Matrix |
| Triad Life Sciences INC. | $21.14 | 2022 | |
| Kci USA, INC. | $19.74 | 2023 | V.A.C. Veraflo, Prevena |
| Access Pro Medical, LLC | $16.87 | 2023 | Matriderm |
| Hydrofera LLC | $16.34 | 2023 | Cutimed Sorbact |
| Inari Medical, INC. | $16.00 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Cvrx, INC. | $10.33 | 2024 | Barostim Neo System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Simone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.